CD4 and neoplasm: The proportion of neutrophil/PMN‐MDSC was dramatically reduced in the tRF‐22 knockdown group, whereas anti‐tumor immune cells, including CD8+ T cells, CD4+ T cells, DC, and NK cells, increased (Figure 2B).